Use of metformin against breast cancer
17 May 2012
Use of metformin against breast cancer
Criteria required before implementation of whole genome arrays in clinical practice
Evidence for TORC1 activation marker as a predictive factor for everolimus efficacy in metastatic breast cancer
Prognostic significance of progesterone receptor-positive tumour cells within luminal A breast cancer
Innovation in molecular imaging
Advances in radiation oncology
EurocanPlatform and the exchange of information
Cervical cancer prevention through screening and vaccination
Cancer diagnosis in teenagers
EONS 2012 lifetime achievement award
Developing new support services for young people with cancer
Non invasive biomarkers for prostate cancer